Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group

CoronaVac vaccine from Sinovac Life Science is currently being used in several countries. In Chile, the effectiveness of preventing hospitalization is higher than 80% with a vaccination schedule. However, to date, there are no data about immune response induction or specific memory. For this reason,...

Descripción completa

Detalles Bibliográficos
Autores principales: Escobar, Alejandro, Reyes-López, Felipe E., Acevedo, Mónica L., Alonso-Palomares, Luis, Valiente-Echeverría, Fernando, Soto-Rifo, Ricardo, Portillo, Hugo, Gatica, Jimena, Flores, Ivan, Nova-Lamperti, Estefanía, Barrera-Avalos, Carlos, Bono, María Rosa, Vargas, Leonardo, Simon, Valeska, Leiva-Salcedo, Elias, Vial, Cecilia, Hormazabal, Juan, Cortes, Lina Jimena, Valdés, Daniel, Sandino, Ana M., Imarai, Mónica, Acuña-Castillo, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841433/
https://www.ncbi.nlm.nih.gov/pubmed/35173705
http://dx.doi.org/10.3389/fimmu.2021.766278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841433/
https://www.ncbi.nlm.nih.gov/pubmed/35173705
http://dx.doi.org/10.3389/fimmu.2021.766278

Ejemplares similares